Fractionated stereotactic radiotherapy for parasellar meningiomas: a preliminary report of visual outcomes.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 15665338.
- Also identified by PMC identifier 1772522.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Fractionated stereotactic radiotherapy (FSRT) is a new treatment for brain tumours that are close to critical structures, such as the visual apparatus. This study aims to assess the visual outcomes for patients with parasellar meningioma following FSRT. A retrospective, non-comparative case series of 13 patients with parasellar meningiomas who were treated in one institution with FSRT between January 1995 and January 2001. 13 patients (26 eyes) were followed for a mean of 2 years. Visual acuity improved in four eyes (12.5%), remained stable in 18 eyes (75%), and worsened in three eyes (12.5%). Visual field improved in 15 eyes (57%), remained stable in six eyes (23%), and worsened in four eyes (15%). No adverse visual outcome occurred as a result of radiation. These preliminary findings suggest that FSRT is a safe and effective treatment for parasellar meningiomas.
Medical subject headings
- Meningeal Neoplasms
- Meningioma